The Pharmacy Quality Alliance (PQA) is seeking comments on its “Proposed Standard Measure Set for Pharmacy Accountability in Value-Based Models.” This set could help implement a new paradigm for collaboration between pharmacies and health plans to improve medication management and patient outcomes.
Included in the proposal are measure concepts relevant to community and specialty pharmacy. The PQA intends to develop the measures with a time-focused approach based on practical deadlines for measure availability for upcoming Medicare plan years.
The proposal was developed by the consensus achieved in a PQA workshop that included community pharmacy, specialty pharmacy, health plan, pharmacy benefit management, and association representatives. Once developed, the measures could be used in value-based models in Medicare Part D and other programs.
In a prepared statement, Laura Cranston, RPh, PQA Chief Executive Officer, emphasized the importance of this proposal.
“PQA stakeholders recognize an expanding role for community pharmacists that can be measured. Pharmacy clinical services and the measures that document them are an important direction for PQA’s measure set in the medium and long term," said Cranston.
PQA member and public comments will be accepted through September 6 at 5:00 pm ET via a form on the PQA website.
Reference
PQA seeks comments on proposed standard measure set for pharmacy accountability in value-based models [news release]. Alexandria, VA: Pharmacy Quality Alliance; August 22, 2019. https://www.pqaalliance.org/measure-set-comment-period. Accessed August 23, 2019.
Article
Comments Sought on Proposed Standard Measure Set for Pharmacy Accountability in Value-Based Models
Author(s):
This set could help implement a new paradigm for collaboration between pharmacies and health plans to improve medication management and patient outcomes.
The Pharmacy Quality Alliance (PQA) is seeking comments on its “Proposed Standard Measure Set for Pharmacy Accountability in Value-Based Models.” This set could help implement a new paradigm for collaboration between pharmacies and health plans to improve medication management and patient outcomes.
Included in the proposal are measure concepts relevant to community and specialty pharmacy. The PQA intends to develop the measures with a time-focused approach based on practical deadlines for measure availability for upcoming Medicare plan years.
The proposal was developed by the consensus achieved in a PQA workshop that included community pharmacy, specialty pharmacy, health plan, pharmacy benefit management, and association representatives. Once developed, the measures could be used in value-based models in Medicare Part D and other programs.
In a prepared statement, Laura Cranston, RPh, PQA Chief Executive Officer, emphasized the importance of this proposal.
“PQA stakeholders recognize an expanding role for community pharmacists that can be measured. Pharmacy clinical services and the measures that document them are an important direction for PQA’s measure set in the medium and long term," said Cranston.
PQA member and public comments will be accepted through September 6 at 5:00 pm ET via a form on the PQA website.
Reference
PQA seeks comments on proposed standard measure set for pharmacy accountability in value-based models [news release]. Alexandria, VA: Pharmacy Quality Alliance; August 22, 2019. https://www.pqaalliance.org/measure-set-comment-period. Accessed August 23, 2019.
Reversal of Executive Order 14087 Raises Questions About Future Drug Pricing Reforms
Public Health Matters: The Importance of Reproductive Justice and Black Maternal Health
High-Sensitivity C-Reactive Protein/High-Density Lipoprotein Cholesterol Ratio Predicts Long-Term Mortality
Pharmacy Focus: Oncology Edition – Key Insights and Interviews From the 2024 SABCS Meeting
Two-Dose Hepatitis E Virus Vaccination Regimen Demonstrates Efficacy, Study Finds
OTC Case Studies: Prenatal Vitamins
Reversal of Executive Order 14087 Raises Questions About Future Drug Pricing Reforms
Public Health Matters: The Importance of Reproductive Justice and Black Maternal Health
High-Sensitivity C-Reactive Protein/High-Density Lipoprotein Cholesterol Ratio Predicts Long-Term Mortality
Pharmacy Focus: Oncology Edition – Key Insights and Interviews From the 2024 SABCS Meeting
Two-Dose Hepatitis E Virus Vaccination Regimen Demonstrates Efficacy, Study Finds
OTC Case Studies: Prenatal Vitamins